Bibliographie (2362)
![[ESMO2020 press release – Not published yet] Randomized trial: No benefit for post-operative radiotherapy in non-small-cell lung cancer](/media/k2/items/cache/d4b22e8d4b1fb6349c7d95bc5629e3c0_L.jpg)
[ESMO2020 press release – Not published yet] Randomized trial: No benefit for post-operative radiotherapy in non-small-cell lung cancer
mardi, 22 septembre 2020 11:29 Écrit par Zouhair SouissiNo benefit for post-operative radiotherapy in non-small-cell lung cancer – European Society of Medical Oncology Commentary: Phase 3 Trial Results Do Not Support PORT in Resected Stage IIIAN2 NSCLC – Targeted Oncology
The post [ESMO2020 press release – Not published yet] Randomized trial: No benefit for post-operative radiotherapy in non-small-cell lung cancer appeared first on Links Medicus.
![[Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials](/media/k2/items/cache/9f9f79e544fb8eb705d18df3c18b9f0a_L.jpg)
[Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials
lundi, 21 septembre 2020 00:38 Écrit par Zouhair SouissiMortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials – medRxiv Commentary on Twitter This meta-analysis of 7,913 patients from 26 RCTs (16 unpublished) found no mortality benefit to #hydroxychloroquine or chloroquine in COVID19 Combined summary OR for all-cause mortality for HCQ 1.08, 95%CI 0.99-1.18 Confirms HCQ does […]
The post [Preprint] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: An international collaborative meta-analysis of randomized trials appeared first on Links Medicus.
Decreased influenza activity during the COVID-19 pandemic
lundi, 21 septembre 2020 00:38 Écrit par Zouhair SouissiDecreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020 – CDC Morbidity and Mortality Weekly Report Commentary: COVID-19 prevention might translate into – MedicalXpress
The post Decreased influenza activity during the COVID-19 pandemic appeared first on Links Medicus.
Severe COVID-19 infections—knowledge gained and remaining questions
lundi, 21 septembre 2020 00:38 Écrit par Zouhair SouissiSevere COVID-19 Infections—Knowledge Gained and Remaining Questions – JAMA Internal Medicine Commentary on Twitter Just out @JAMAInternalMed – our editorial on what we've learned about severe #Covid19 pneumonia so far and what challenges are still ahead. Honored and proud to have written this together with Carolyn Calfee and Dan Brodie. https://t.co/rmVjUWNyvM — Lieuwe Bos […]
The post Severe COVID-19 infections—knowledge gained and remaining questions appeared first on Links Medicus.
Editorial: Convalescent plasma for Covid-19
dimanche, 20 septembre 2020 23:35 Écrit par Zouhair SouissiConvalescent plasma for covid-19 – The BMJ Commentary on Twitter Last month the US FDA authorised the emergency use of convalescent plasma for hospital patients with covid-19. What evidence underpinned the FDA’s controversial decision? And will the authorisation make it more difficult to recruit participants for RCTS? https://t.co/PMO13J2IOq — The BMJ (@bmj_latest) September 19, […]
The post Editorial: Convalescent plasma for Covid-19 appeared first on Links Medicus.
Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19
dimanche, 20 septembre 2020 23:35 Écrit par Zouhair SouissiComparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations – Critical Care
The post Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19 appeared first on Links Medicus.
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
vendredi, 18 septembre 2020 12:07 Écrit par Zouhair SouissiClustering and superspreading potential of SARS-CoV-2 infections in Hong Kong – Nature Medicine Commentary: Superspreaders of SARS-CoV-2 – Virology Blog Commentaries on Twitter Cases linked to #superspreading events are estimated to account for 80% of all local transmission of #SARSCoV2 in Hong Kong in a study with implications for public health policies. @bencowling88 @gmleunghku […]
The post Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong appeared first on Links Medicus.
The pooled prevalence of pulmonary embolism in patients with COVID-19
vendredi, 18 septembre 2020 12:07 Écrit par Zouhair SouissiThe pooled prevalence of pulmonary embolism in patients with COVID-19 – Intensive Care Medicine Commentary on Twitter Pulmonary embolism in #COVID19, be careful! quantitative meta-analysis ->pooled prevalence in pts undergoing #PE diagnosis 28%higher pooled prevalence in pts admitted to #ICU vs those admitted to non-ICU: 19 vs 9%Open access @yourICM #COVIDFOAM #FOAMcc https://t.co/dUqKAVoeCV pic.twitter.com/fvmQnTlv1M […]
The post The pooled prevalence of pulmonary embolism in patients with COVID-19 appeared first on Links Medicus.
Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A narrative review
vendredi, 18 septembre 2020 12:07 Écrit par Zouhair SouissiPulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review – Annals of Intensive Care
The post Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A narrative review appeared first on Links Medicus.
Covid-19: Do many people have pre-existing immunity?
vendredi, 18 septembre 2020 12:07 Écrit par Zouhair SouissiCovid-19: Do many people have pre-existing immunity? – The BMJ Commentary on Twitter It seemed a truth universally acknowledged that the human population had no pre-existing immunity to SARS-CoV-2, but is that actually the case? Peter Doshi explores the emerging research on immunological responseshttps://t.co/6LYRjxlWBQ — The BMJ (@bmj_latest) September 17, 2020
The post Covid-19: Do many people have pre-existing immunity? appeared first on Links Medicus.
![[Press release – not published yet] Eli Lilly reports first, promising results for an antibody against COVID-19](/media/k2/items/cache/8240a1907e29481b04619a0df33df9ab_XS.jpg)
